Etanercept and Adalimumab Treatment Patterns in Psoriatic Arthritis Patients Enrolled in a Commercial Health Plan

被引:0
作者
Benjamin Chastek
Kathleen M. Fox
Crystal Watson
Shravanthi R. Gandra
机构
[1] OptumInsight,
[2] Strategic Healthcare Solutions,undefined
[3] LLC,undefined
[4] Amgen Inc.,undefined
来源
Advances in Therapy | 2012年 / 29卷
关键词
Adalimumab; Etanercept; Discontinuation; Persistence; Psoriatic arthritis; Switch; Treatment patterns;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:691 / 697
页数:6
相关论文
共 50 条
  • [31] Infection risk in patients with rheumatoid arthritis treated with etanercept or adalimumab
    Chiang, Yi-Chun
    Kuo, Li-Na
    Yen, Yu-Hsuan
    Tang, Chao-Hsiun
    Chen, Hsiang-Yin
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2014, 116 (03) : 319 - 327
  • [32] Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
    Rosalía Martínez-Pérez
    Sergio Rodríguez-Montero
    Alejandro Muñoz
    Julia Uceda
    Mario León
    Francisco Gallo
    Maria Luisa Velloso
    José Luis Marenco
    Journal of Translational Medicine, 9 (Suppl 2)
  • [33] ETANERCEPT TREATMENT IN A RESISTANT CASE WITH PSORIATIC ARTHRITIS
    Capkin, Erhan
    Karkucak, Murat
    Ozden, Gonca
    Tosun, Mehmet
    Cakirbay, Hasim
    NOBEL MEDICUS, 2011, 7 (01): : 112 - 114
  • [34] Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment
    Boggs, Robert L.
    Karpti, Sarolta
    Li, Wenzhi
    Williams, Theresa
    Pedersen, Ronald
    Mallbris, Lotus
    Gniadecki, Robert
    BMC DERMATOLOGY, 2014, 14
  • [35] The Treatment of Ankylosing Spondylitis and Psoriatic Arthritis with Etanercept: A Comprehensive Review
    Collamer, Angelique N.
    Battafarano, Daniel F.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 27 - 43
  • [36] Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist
    Wong, VK
    Lebwohl, MG
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (11) : 1505 - 1513
  • [37] Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept
    Mease, PJ
    Ritchlin, CT
    Martin, RW
    Gottlieb, AB
    Baumgartner, SW
    Burge, DJ
    Whitmore, JB
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (07) : 1356 - 1361
  • [38] Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice
    Ramirez-Herraiz, E.
    Escudero-Vilaplana, V.
    Alanon-Plaza, E.
    Trovato-Lopez, N.
    Herranz-Alonso, A.
    Morell-Baladron, A.
    Sanjurjo-Saez, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : 559 - 565
  • [39] A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis
    Yazici, Y
    Erkan, D
    Lockshin, MD
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (06) : 732 - 734
  • [40] Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis
    Saraceno, Rosita
    Bavetta, Mauro
    Zangrilli, Arianna
    Chiricozzi, Andrea
    Potenza, Concetta
    Chimenti, Sergio
    Chimenti, Maria Sole
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1325 - 1334